Press Releases

Headillu

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

back 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 next

15.03.2010	Dabigatran etexilate shows greater reductions than warfarin in stroke in patients with atrial fibrillation across all stroke risk groups - For NON-US Healthcare Media Only
23.02.2010	The third "European Porcine Circovirus Research Award" honours scientists from Spain and Denmark
10.02.2010	Boehringer Ingelheim announces its intention to acquire all the outstanding shares in SSP Co., Ltd. ("SSP") through a tender offer
27.01.2010	Metacam® receives EU approval for the relief of pain in castrated piglets
18.01.2010	Boehringer Ingelheim and Priaxon announce a collaboration to research and develop novel treatments for cancer
11.01.2010	Largest pig producing country China approves novel vaccine against widespread pig disease
17.12.2009	Boehringer Ingelheim initiates first Phase III clinical trial in Ovarian Cancer - For Non-US Media only
06.12.2009	Milestone results in RE-COVER™ study – novel oral direct thrombin inhibitor dabigatran etexilate – as effective as well controlled warfarin with less bleeding in treatment of acute venous thromboembolism - For Media outside the US and the UK
02.12.2009	Milestone results assessing novel anticoagulation dabigatran etexilate versus warfarin in the treatment of acute deep vein thrombosis and pulmonary embolism to be presented at ASH 2009 - For Medical Media outside the US and the UK
27.11.2009	Major European regulatory milestone in cardiovascular protection for Micardis® (telmisartan): Now approved by the European Commission to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients - For medical media, outside the US only
27.11.2009	Boehringer Ingelheim and Vectura conclude collaboration
18.11.2009	Boehringer Ingelheim and GlaxoSmithKline back EFA`s call for urgent improvements in care for people with lung disease this World COPD Day
16.11.2009	Flibanserin Demonstrates Efficacy and Tolerability in Pivotal Phase III Trials in Pre-Menopausal Women with Hypoactive Sexual Desire Disorder (HSDD) - For medical media, outside the US only
02.11.2009	Boehringer Ingelheim announces record productivities for CHO cells using the BI-HEX technology platform
29.10.2009	Heinrich Wieland Prize 2009 awarded for outstanding achievements in the synthesis of key natural products
26.10.2009	Boehringer Ingelheim Animal Health closes deal to acquire a significant portion of the Fort Dodge Animal Health Business from Pfizer - For medical media, outside the US only
23.10.2009	CHMP issues positive opinion for Micardis® (telmisartan) as the first treatment in its class to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients - For medical media, outside the US only
19.10.2009	FDA approves Twynsta® (telmisartan plus amlodipine) a new single pill combination that delivers powerful and consistent blood pressure reductions throughout 24 hours - For medical media, outside the US only

back 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 next

back to top

Contact

Boehringer Ingelheim GmbH

Corporate Headquarters
Binger Str. 173
55216 Ingelheim
Germany

Phone +49 / 6132 / 77 0
Fax +49 / 6132 / 72 0

ContactContactBoehringer Ingelheim GmbHBoehringer Ingelheim GmbH

Corporate Headquarters
Binger Str. 173
55216 Ingelheim
Germany

Phone +49 / 6132 / 77 0
Fax +49 / 6132 / 72 0

Corporate Headquarters
Binger Str. 173
55216 Ingelheim
Germany

Phone +49 / 6132 / 77 0
Fax +49 / 6132 / 72 0

media contactsmedia contacts media contacts

RSS feeds allow you to receive latest news and information about Boehringer Ingelheim.

subscribe to RSS Feed

RSS feeds allow you to receive latest news and information about Boehringer Ingelheim.

RSS feeds allow you to receive latest news and information about Boehringer Ingelheim.

subscribe to RSS Feed